Edoxaban p-toluenesulfonate monohydrate
98%
- Product Code: 124890
CAS:
1229194-11-9
Properties:
This product is for scientific research only
| Molecular Weight: | 738.28 g./mol | Molecular Formula: | C₃₁H₄₀ClN₇O₈S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28400751 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Edoxaban p-toluenesulfonate monohydrate is primarily used as an anticoagulant in the prevention and treatment of thromboembolic disorders. It is specifically prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Additionally, it is utilized for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and to prevent recurrence of these conditions. Its mechanism involves inhibiting Factor Xa, which plays a key role in the blood coagulation cascade, thereby preventing the formation of blood clots. It is often chosen for its oral bioavailability and predictable pharmacokinetics, making it a convenient option for long-term anticoagulation therapy.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White To Yellow Powder, Crystals Or Chunks |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿5,300.00 |
+
-
|
| 1.000 | 10-20 days | ฿15,250.00 |
+
-
|
| 5.000 | 10-20 days | ฿55,000.00 |
+
-
|
Edoxaban p-toluenesulfonate monohydrate
Edoxaban p-toluenesulfonate monohydrate is primarily used as an anticoagulant in the prevention and treatment of thromboembolic disorders. It is specifically prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Additionally, it is utilized for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and to prevent recurrence of these conditions. Its mechanism involves inhibiting Factor Xa, which plays a key role in the blood coagulation cascade, thereby preventing the formation of blood clots. It is often chosen for its oral bioavailability and predictable pharmacokinetics, making it a convenient option for long-term anticoagulation therapy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :